Mathematical approach for estimating iron needs in hemodialysis patients on erythropoietin therapy

American Journal of Nephrology

Volumn 17, Issue 2, 1997, Pages 158-164

  Tarng, Der Cherng ^a   Huang, Tung Po ^a   Chen, Tzen Wen ^a  

^a NATIONAL YANG MING UNIVERSITY   (Taiwan)

Author keywords

Erythropoietin; Ferritin; Functional iron deficiency; Iron requirements; Transferrin saturation

Indexed keywords

ANTIANEMIC AGENT; FERRIC OXIDE; FERRITIN; HEMOGLOBIN; IRON; RECOMBINANT ERYTHROPOIETIN; TRANSFERRIN;

ADULT; AGED; ANEMIA; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; ERYTHROPOIESIS; FEMALE; FERRITIN BLOOD LEVEL; HEMODIALYSIS PATIENT; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; IRON DEFICIENCY; IRON METABOLISM; IRON STORAGE; IRON THERAPY; MALE; MATHEMATICS; NOMOGRAM; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SUBCUTANEOUS DRUG ADMINISTRATION; TRANSFERRIN BLOOD LEVEL;

EID: 0030975974     PISSN: 02508095     EISSN: 14219670     Source Type: Journal    
DOI: 10.1159/000169091     Document Type: Article

References (37)

1. Bainton DF, Finch CA: The diagnosis of iron deficiency anemia. Am J Med 1964:37:62-70.
2. Eschbach JW, Egrie JC, Downing MR, Browne JK, Adamson JW: Correction of the anemia of end-stage renal disease with recombinant human erythropoietin: Results of a combined phase I and II clinical trial. N Engl J Med 1987: 316:73-78.
3. Schaefer RM, Hörl WH, Massry SG: Treatment of renal anemia with recombinant human erythropoietin. Am J Nephrol 1989:9:353-362.
4. Macdougall IC, Hutton RD, Gravil] I, Coles GA, Williams JD: Poor response to treatment of renal anemia with erythropoietin corrected by iron given intravenously. Br Med J 1989: 299:157-158.
5. Macdougall IC, Hutton RD, Gravill I, Coles GA, Williams JD: Treating renal anaemia with recombinant erythropoietin: Practical guidelines and a clinical algorithm. Br Med J 1990; 300:655-659.
6. Casati S, Campise M, Ponticclli C: Correction of anemia with recombinant human erythropoietin despite low serum ferritin. Nephrol Dial Transplant 1991;6:452-456.
7. Kooistra MP, Van Es A, Struyvcnberg A, Marx JJM: Iron metabolism in patients with the anaemia of end-stage renal disease during treatment with recombinant human erythropoietin. Br J Haematol 1991:79:634-639.
8. Griltzmachcr P, Tsobanelis T, Roth P, Werner E, Vlachojannis J, Kallwasser J, Kurz P, Scheuermann EH, Schoeppe W: Effect of recombinant human erythropoietin on iron balance in maintenance hemodialysis: Theoretical consideration, clinical experience and consequences. Clin Nephrol 1992;38(suppl 1):92-97.
9. Tarng DC, Chen TW, Huang TP: Iron metabolism indices for early predicting the response and resistance to erythropoietin therapy in maintenance hemodialysis patients. Am J Nephrol 1995;15:230-237.
10. Beguin BY, Loo M, R’zik S, Sautois B, Lejeune F, Rorive G, Fillet G: Early prediction of response to recombinant human erythropoietin in patients with the anemia of renal failure by serum transferrin receptor and fibrinogen. Blood 1993:82:2010-2016.
11. Van Wyck DB, Stivelman JC, Ruiz J, Kirlin LF, Katz MA, Ogden DA: Iron status in patients receiving erythropoietin for dialysis-related anemia. Kidney Int 1989:35:712-716.
12. Cook JD, Skikne BS, Lynch SR, Reusser ME: Estimates of iron deficiency in the US population. Blood 1986:68:726-731.
13. Jacob RA, Sandstead HH, Klcvay LM, Johnson LK: Utility of serum ferritin as a measure of iron deficiency in normal males undergoing repetitive phlebotomy. Blood 1980:56:786-791.
14. Cook JD: Clinical evaluation of iron deficiency. Semin Hcmatol 1982;19:6-18.
15. Stivelman JC: Resistance to recombinant human erythropoietin therapy: A real clinical entity? Semin Nephrol 1989:9(suppl 2):8-l1.
16. Drücke TB: Resistance to recombinant human erythropoietin in hemodialysis. Am J Nephrol 1990; 10(suppl 2):34-39.
17. O’neill-Cutting MA. Crosby WH: The effect of antacids on the absorption of simultaneously ingested iron. JAMA 1986:255:1468-1470.
18. Lindsay RM, Burton JA, Edward N, Dargie HJ, Prenlici CRM, Kennedy AC: Dialyzer blood loss. Clin Nephrol 1973; 1:29-34.
19. Longneckcr RE, Gofiinet JA, Hendler ED: Blood loss during maintenance hemodialysis. Trans Am Soc Artif Intern Organ 1974;20: 135-140.
20. Milman N, Larsen L: Iron absorption in patients with chronic uremia undergoing regular hemodialysis. Acta Med Scand 1976:199:113-119.
21. Ali M, Faycmi AO, Rigilosi R, Francino J, Marsden T, Malcolm D: Hemosiderosis in he-modialvsis patients. JAMA 1980:244:343-345.
22. Kothari T, Swamy AP, Lee JCK, Mangla JC, Cestero RVM: Hepatic hemosiderosis in maintenance hemodialysis patients. Dig Dis Sci 1980:25:363-368.
23. Tomson CRV: Erythropoietin: What problems remain in 1994? Nephrol Dial Transplant 1994;9:344-345.
24. Boclaert JR, Daneels RF, Schurgers ML, Mat-thys EG, Gordts BZ, Van Landuyt HW: Iron overload in haemodialysis patients increases the risk of bacteraemia: A prospective study. Nephrol Dial Transplant 1990:5:130-134.
25. Kooistra MP, van Es A, Struyvenberg A, Marx JJM: Iziw iron absorption in erythropoietin-treated haemodialysis patients. J Am Soc Nephrol 1995:6:543.
26. Anastassiades EG, Howarth D, Howarth J, Shanks D, Waters HM, Hyde K, Geary CG, Liu Yin JA, Gokal R: Monitoring of iron requirements in renal patients on erythropoietin. Nephrol Dial Transplant 1993:8:846-853.
27. Fishbanc S, Lynn RI: The efficacy of iron dex-tran for the treatment of iron deficiency in hemodialysis patients. Clin Nephrol 1995:44: 238-240.
28. Roscnlof K, Kivivuori SM, Gronhagcn-Riska C, Teppo AM, Slimes MA: Iron availability is transiently improved by intravenous iron medication in patients on chronic hemodialysis. Clin Nephrol 1995:43:249-255.
29. Jacobs A, Miller F, Worwood Beamish MR, Wardrop CA: Ferritin in the scrum of normal subjects and patients with iron deficiency and iron overload. Br Med J 1972:iv:206-208.
30. Hussein S, Prieto J, O’shea M, Hoffbrand AV, Baillod RA, Moorhead JF: Serum ferritin assay and iron status in chronic renal failure and hemodialysis. Br Med J 1975;i:546-548.
31. Bell JD, Kincaid WR, Morgan RG, Bunce H III, Alperin JB, Sarles HE, Remmers AR Jr.: Serum ferritin assay and bone marrow iron stores in patients on maintenance hemodialysis. Kidney Int 1980;17:237-241.
32. Mirahmadi KS, Paul WL, Winer RL, Dabir VN, Byer B, Gorman JT, Rosen SM: Serum ferritin level: Determinant of iron requirement in hemodialysis patients. JAMA 1977:237: 601-603.
33. Blumberg AB, Marti HRM, Graber CG: Scrum ferritin and bone marrow iron in patients on ongoing continuous ambulatory peritoneal dialysis. JAMA 1983:250:3317-3319.
34. Walters GO, Miller FM, Worwood M: Serum ferritin concentration and iron stores in normal subjects. J Clin Pathol 1973:26:770-772.
35. Charlton RW, Derman D, Skikne BS, Torrance JD, Lynch SR, Zwi S, Goldman HI, Van As A, Margo G, Bothwcll TH: Anaemia, iron deficiency and exercise: Extended studies in human subjects. Clin Sci Mol Med 1977;53:537-541.
36. Moreb J, Popovtzer PP, Friedlaender MM, Konijn AM, Hershko C: Evaluation of iron status in patients on chronic hemodialysis: Relative usefulness of bone marrow hemosiderin, serum ferritin, transferrin saturation, mean corpuscular volume and red cell protoporphyrin. Nephron 1983;35:196-200.
37. Van de Vyver FL, Vanheule AA, Majelyne WM, D’haese P, Blockx PP, Bekaert AB, Buyssens N, De Keersmaccker W, De Broe ME: Scrum ferritin as a guide for iron stores in chronic hemodialysis patients. Kidney Int 1984:26:451-458.